GLPwatch
Selective amylin receptor agonism: promise beyond incretins.
Lancet · 2025
Last updated 2026-09-22| Journal | Lancet, 2025 |
|---|---|
| Citations | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Full record and abstract on PubMed 41207309 ↗
Lancet · 2025
Last updated 2026-09-22| Journal | Lancet, 2025 |
|---|---|
| Citations | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Full record and abstract on PubMed 41207309 ↗